
Therma Bright Inc's stock is making waves with a notable surge in value, driven by strategic developments and market confidence.
Therma Bright Inc (THRM.V) is rising today, up 11.11% to CA$0.05 as investors respond positively to recent developments. The company's strategic moves in the medical equipment sector are attracting attention and driving stock performance.
Advertisement
Therma Bright Inc
THRM.V
THRM.V
Therma Bright Inc
Advertisement
Market cap
$3.06M
52W high
$0.12
52W low
$0.04
1W change
+0.00%
Beta
1.13
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on THRM's historical volatility
30-Day Vol
121.3%
Annualized
90-Day Vol
92.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.07 |
| 60 trading days | C$0.04 | C$0.02 – C$0.08 |
| 90 trading days | C$0.04 | C$0.02 – C$0.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on Therma Bright's growth trajectory, particularly in the U.S. market, as the company secures significant orders and expands its product offerings.
Therma Bright's stock jumps 11.11% today
This increase reflects growing investor interest and confidence in the company's strategic initiatives.
Bull case
The recent order from Horizon Health for 100 units of the Venowave™ product shows strong demand and potential for revenue growth. This could boost investor confidence even more.
Bear case
Despite the current surge, investors should be cautious. The company's market cap is still relatively small at CA$3.06 million, and it has yet to establish profitability.
Advertisement
Strategic Growth in the U.S. Market
Therma Bright's recent announcement of securing a 100-unit order from Horizon Health marks a pivotal moment for the company. This order not only enhances its market presence but also reflects the growing demand for its Venowave™ product in the U.S. vascular recovery market. Such strategic partnerships are crucial for Therma Bright as it aims to expand its footprint in a competitive industry.
Investor Sentiment and Market Performance
The 11.11% rise in Therma Bright's stock today indicates a positive shift in investor sentiment. As the company continues to secure contracts and expand its product offerings, investors are likely to view these developments as a sign of potential future profitability. However, with a market cap of just CA$3.06 million, cautious optimism is warranted as the company navigates its growth path.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


